MiNK Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2024 | 2 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
MiNK Therapeutics, Inc. Earnings Date And Information
MiNK Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MiNK Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.65 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. MiNK Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based on prior year's report dates.
MiNK Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.08 | -$45.70 | -45.62 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$0.10 | -$0.07 | 0.03 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.16 | -$0.11 | 0.05 | $0 | |
| 03/21/2024 | Q4 2023 | -$0.15 | -$0.16 | -0.01 | $-11,708,192,000 | |
| 11/14/2023 | Q3 2023 | -$0.15 | $0 | |||
| 08/10/2023 | Q2 2023 | -$0.19 | -$0.18 | 0.01 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.24 | $4.79 | 5.03 | $11.71 B | |
| 03/24/2023 | Q4 2022 | -$0.22 | $2.70 B | |||
| 11/03/2022 | Q3 2022 | -$0.23 | -$0.14 | 0.09 | $1.56 B | |
| 08/15/2022 | Q2 2022 | -$0.13 | $1.56 B | |||
| 05/13/2022 | Q1 2022 | -$0.24 | $0 | |||
| 03/18/2022 | Q4 2021 | -$0.24 | -$0.18 | 0.06 | $221.92 M | |
| 11/29/2021 | Q3 2021 | -$0.20 | -$0.43 | -0.23 | $0 | |
| 06/29/2021 | Q2 2021 | -$0.22 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.14 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.05 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.21 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.18 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.18 | $0 |
MiNK Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is MiNK Therapeutics, Inc.'s earnings date?
MiNK Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates.
-
Did MiNK Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, MiNK Therapeutics, Inc. (:INKT) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.03.
-
How can I listen to MiNK Therapeutics, Inc.'s earnings conference call?
The conference call for MiNK Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read MiNK Therapeutics, Inc.'s conference call transcript?
The conference call transcript for MiNK Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does MiNK Therapeutics, Inc. generate each year?
MiNK Therapeutics, Inc. (:INKT) has a recorded net income of $0. MiNK Therapeutics, Inc. has generated $-0.65 earnings per share over the last four quarters.
-
What is MiNK Therapeutics, Inc.'s price-to-earnings ratio?
MiNK Therapeutics, Inc. (:INKT) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is 0.
